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ABSTRACT 
“Iodine nutritional status in children with acquired hypothyroidism” 
Hypothyroidism causes significant growth and mental retardation. 
The existing Universal Salt Iodization program has led to the reduction in 
Iodine Deficiency Disorders in endemic population groups. Inspite of 
this, prevalence of goiter is 13%, childhood hypothyroidism is 3% and 
Subclinical hypothyroidism is 10% in our country. Experience from 
southeast Asian countries also shows increase in detection of Juvenile 
autoimmune thyroiditis in post –iodization assessment. Urinary iodine is 
the prime indicator of a person’s iodine nutritional status. Hence this 
study is done to assess the iodine nutritional status in children with 
acquired hypothyroidism and healthy school children. 
Objectives 
Primary Objective 
To find out the iodine nutritional status in children with acquired 
hypothyroidism of age 2-12 years attending tertiary care centre  
 
Secondary Objective 
To assess changes in iodine nutritional status in autoimmune 
thyroiditis 
Study Method 
Descriptive study 
Study Population  
61 cases of acquired hypothyroidism and 102 healthy children from 
2 different schools in Chennai.  
Materials and Methods 
         Children with acquired hypothyroidism of age 2-12 years attending 
a tertiary care center were evaluated with history, clinical examination, 
goiter grading, antithyroid antibody levels, urinary iodine levels, 
ultrasound and FNAC thyroid gland if goiter is present. Urinary iodine 
levels were assessed in 102 healthy schoolchildren. If the iodine levels 
were more than adequate, >200μg/l they were further evaluated with 
thyroid function tests, antiTPO antibody and Thyroglobulin antibody 
levels. 
Results  
The mean urinary iodine level in cases were 440.2 and 789.9 in 
healthy school children. Female : Male ratio was 2.7:1. Ultrasound is as 
sensitive as FNAC in diagnosing thyroiditis. 
Conclusion   
Autoimmune thyroiditis is the most common cause of acquired 
hypothyroidism. Iodine deficiency is no longer the cause of 
hypothyroidism. There is no correlation between urinary iodine levels and 
antithyroid antibody levels.  
Keywords:  
Urinary iodine levels, anti TPO antibodies, anti Thyroglobulin 
antibodies, autoimmune thyroiditis 
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INTRODUCTION 
Thyroxine and triiodothyronine profoundly increase the metabolic 
rate of the body.  Complete lack of thyroxine can cause the metabolic rate 
of the body to fall by 40 to 50 % below normal. Thyroxine and 
triiodothyronine increase the consumption of oxygen, stimulates the 
synthesis of proteins thereby promoting growth of the body, CNS 
development and affect the metabolism of both micro and macronutrients. 
 
Anatomy 
Thyroid gland is an endocrine organ which is present in front of the 
neck between the cricoid cartilage and the sternum. The gland has two 
lobes connected by a narrow median isthumus. No significant difference 
in thyroid gland volume has been observed between males and females 
from 8 months to 15 years. The blood supply to the gland comes from 
paired superior and inferior thyroid arteries (originate from external 
carotid artery) and an inconstant artery, the thyroidea ima. The blood is 
drained via the venous plexus in the fibrous capsule. Thyroid has a rich 
supply of lymphatics. Those draining superior portion of the gland and 
the isthumus collect in to internal jugular lymph nodes and those draining 
the inferior portions collect into pre and para-tracheal lymph nodes 
 
 
2 
 
Anatomy of Thyroid gland 
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Histology 
The gland consists of two functionally and morphologically 
distinct endocrine systems. The principle component of the gland being 
follicles made up of the thyrocyte or follicular cell proper and the second 
minor endocrine component being parafollicular or C cells. In addition to 
the above two, there is a third anatomical structure of unknown 
physiologic significance constituting ultimobranchial remanants. The 
follicles are filled with colloid which contains thyroglobulin. Thyroid 
hormones are stored as thyroglobulin, a large protein with numerous 
residues of iodinated thyroid including biologically active T3 and T4. 
When the gland is activated by TSH to release thyroid hormones, the 
endocytosis of colloid and proteolysis of thyroglobulin by lysosomal 
enzymes occur. 
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Histology of Thyroid gland   
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Thyroxine synthesis 
The production of thyroxine and triiodothyronine are closely 
related to iodine metabolism as both of these hormones contain high 
content of iodine. Both of these hormones have similar action but differ 
in their course and time of action.(12)  
The first step in the production of thyroxine is the trapping of 
iodide by sodium iodide symporter into the lumen of thyroid follicles. 
Iodide is converted to oxidised iodine with the help of peroxidise and 
hydrogen peroxide. The oxidised iodine binds with tyrosine aminoacids 
of thyroglobulin in the presence of iodinase, the process known as 
organification of thyroglobulin to form mono and diiodotyrosine. They 
couple to form thyroxine and triiodothyronine which are stored in the 
thyroglobulin molecules. 
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The thyroid gland is unique in the fact that it is the only endocrine 
gland which can store the hormones for months and release it into the 
circulation slowly when needed.  The stores are sufficient for 3 months. 
Thyroxine when needed, the epithelial cells send pseudopodia into the 
lumen and they endocytose thyroglobulin.  Each thyroglobulin contains 1 
to 3 thyroxine molecules and 1 triiodothyronine molecule for each 14 
thyroxine.  Thyroxine and triiodothyronine are cleaved from the  
 
 
 
 
 
 
 
 
 
thyroglobulin molecules with the help of proteases and peptidases present 
in the lysosomal enzymes and released into the circulation.  In the 
circulation 98% of hormones bind with thyroid binding globulin, thyroid 
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binding prealbumin and albumin. This is to prevent rapid degradation by 
liver, kidney and peripheral tissues.  In the thyroid gland T4 constitutes 
35%, T3 constitutes 5%, and the rest is DIT and MIT.  
T4 is highly protein bound and is stable, it is the extracellular 
hormone. 
T3 is less protein bound. It is more potent than thyroxine . It enters 
the cells rapidly and acts. Half life of thyroxine is 6 days while that of 
triiodothyronine is 1-3 days. 
  T3 is 3-4 times more potent than thyroxine. Only 20% T3 is 
produced by thyroid gland while the rest is formed from thyroxine by 
deiodinase enzyme in the liver, kidney and peripheral tissues.  
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Feedback mechanism 
Thyrotropin releasing hormone is produced by hypothalamus. 
Thyroid stimulating hormone is produced by anterior pituitary. 
Thyroxine and T3 are produced by thyroid gland. 
All the hormones are highly interlinked. When thyroxine is low, it 
stimulates the production of Thyrotropin releasing hormone which in turn 
stimulates the production of TSH which increases the production of 
thyroxine. 
Initially this change occurs only at molecular level. If there is 
persistent hypothyroidism, excessive TSH will cause hyperplasia of 
thyroid gland hence goitre occurs. Also in hyperthyroidism there may be 
enlargement of thyroid gland.  
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Iodine deficiency disorders: 
Defective iodine intake could lead on to certain bad effects like 
goiter, mental and growth retardation.  This can be prevented by taking 
adequate iodine in food.. Erosion of soil in riverine area ,excessive tree 
cutting, overgrazing by livestock have led to loss of iodine from soil. 
Hence crops grown in that area lack in iodine. Hilly areas are also 
deficient in iodine. Iodine deficiency can lead to goiter, mental and 
growth retardation, still birth, defects in speech, hearing and vision. The 
children living in iodine deficient areas had 13.5 Intelligence quotient 
points lower than iodine replete areas. 
130 countries and two million people were found to be affected 
with Iodine deficiency disorders, affecting One third of the population.  
6.1 crore people in india  are  suffering from iodine deficiency goiter. 
And 88 lakh people have growth or mental retardation. 
Therefore after a successful trial of iodization of salt in kangara 
valley, Government of India launched a 100% centrally sponsored 
programme named National goiter control programme(NGCP) in 1962. 
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Objectives of NIDDCP 
1. Magnitude of the problem of IDD in the country must be surveyed; 
2. Endemic region must be supplied with iodised salt; 
3. Health Education; 
4. To monitor the quality of iodized salt by assessing urinary iodine 
excretion pattern and assessing the magnitude of Iodine Deficiency 
disorder and 
5. Every five years all the areas must be surveyed. The last survey in 
the endemic areas were not satisfactory. 
  
 The National Goiter Control Programme (NGCP) was converted to 
National Iodine Deficiency Disorder Control Programme (NIDDCP). 
NIDDCP in 1992, recommended universal salt iodization. 
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Universal salt iodization is achieved when iodine is present in the food 
for human and animal consumption. 
 
 
According to WHO declaration, 2001 elimination of iodine deficiency 
disorders shall be maintained only when  
1. The median urinary iodine excretion is 100 μg/l.  <20% being 
below 50 μg/l. 
2. > 90% households should be using salt which has iodine content of 
15 parts per million or more.   
Iodized salt was brought under the revised Prevention of Food 
Adulteration (PFA) Act of 1988. 
 
 
 
  
Population Levels recommended 
Preschool Children 90µg 
School Children 120µg 
Adults 150µg 
Pregnant and breast feeding women 200µg 
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WHO recommended that in special circumstances where  
1. 20 %loss of iodine from salt from production site to households 
2. During cooking loss is 20%  
3. Person must take atleast10g per person per day 
At the production site concentration of iodine in salt should be     
20-40 ppm iodine per kg of salt so that a person avails 150μg of iodine 
per person per day. Salt must not be transported in gunny bags. Plastic 
bags must be used. 
>90% households are using   iodised salt in 30countries.  Hence we 
have achieved the goal of universal salt iodisation. South east asian 
countries have achieved 70% iodised salt consumption. In India as per the 
Coverage Evaluation Survey 2009, 91 per cent of households had access 
to iodized salt, of whom 71 per cent consumed adequately iodized salt. 
Another 9 per cent consume non-iodised consumed salt. 
Iodine is particularly essential for pregnant women as the iodine 
deficiency can cause abortion, still birth and affect the development of 
fetus.  It is also important for the first two years of life as this is the 
period where the brain development occurs. 
In areas where iodisation is not possible up to the mark, in order to 
provide essential iodine to children and pregnant women, the following 
things are done. 
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1. Administration of iodised oil capsules once in 6-18 months. 
2. Lugol’s iodine administration once in a month. 
3. Water supply must be iodized by adding iodine solution with 
special instruments. 
In 1991,total goiter rate was 13% of the world population affecting 
740 million people. Salt coverage had increased to 70% in south east asia. 
Between 1994 t0 2006, 94 Countries had conducted urinary iodine 
survey. 
Thus we have data only on 91% of the world’s population.  Still we 
are lacking data on 8.9% of the population of the world. 
 
Year 
Number of countries endemic 
To IDD 
2006 47 
2004 54 
1993 126 
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Iodine Intake  
Adequate 76% 
Excessive 7% 
Insufficient 31% 
 
SALT IODIZATION PROCESS 
Salt is iodized by additional fixed amount Potassium Iodate (KIO3) 
or Potasium Iodide as an aqueous form or dry powder form, at the 
production site. 
The amount of Iodine supplemented depends on the recommended 
amount for that country.  Iodate is recommended than iodide as it is much 
more stable.  The moisture content of the salt is maintained by improving 
packaging and storage of the salt.  This is required for maintaining the 
stability of iodine in the salt. 
By using small (500 to 1 kg) polyethylene bags loss of iodine was 
reduced by 30-80%.  This is made possible by film insert and 
polyethylene bags.  The loss is 10% over an 18 month period. 
This was very much less when iodized salt was stored in large 
amounts in gunny bags. 
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TESTING OF IODINE LEVEL IN SALT 
The amount of iodine in salt can be determined in quantity by 
titration method and by rapid test kits qualitatively. 
Titration method 
 Titration method involves preparation of 4 solutions and a standard 
solutions which can be used for a variable time, and then assessing the 
Iodine content in the salt solution by adding solutions which are already 
prepared and then titrated. 
Principle 
 The iodine present in the salt is liberated and in the presence of 
starch as indicated, iodine is titrated against sodium thiosulphate. This 
method changes depending on iodate or iodide is used in iodizing the salt. 
Rapid test kits 
 These kits contain 10 to 15 ml bottle with stabilizing starch 
containing solution. Then 1 drop of this solution is added to the solution 
of iodized salt.  
Colour change to blue or purple indicates that iodine is present. 
When the salt is more alkaline, recheck solution is added. 
This is only qualitative but not quantitative and must be rechecked 
by titration method. The advantage of this kit is that they are easy to carry 
and these tests can be done at the production site. 
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It can be also be done at the house hold level and we can check the 
availability of iodine at the household level.  
These kits have been provided to environmental health officers, 
nutrition officer, school teacher, mayors, community midwives and other 
government workers who are responsible for health. This is helpful in 
checking the content of iodine  at both the production site and house hold 
level and has helped us in managing the IDD problem. 
 
INDICATORS OF IMPACT 
1. Urine Iodine 
2. Goiter by palpation and by ultra sound 
3. Blood levels of TSH and Thyroglobulin 
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URINARY IODINE 
Only one fifth of the iodine which is ingested by the person is 
utilized by the thyroid gland. Others will be excreted in urine. Hence the 
iodine nutritional status of the person can be assessed by measuring the 
urinary iodine level. 
There will be day to day variation in the urinary iodine levels and 
also there will be variation in the same day in the same individual but this 
problem can be evened out by measuring the median urinary iodine level 
of the population.  
Urine iodine creatinine ratio was previously used. This is not 
reliable as the creatinine content of urine of a person varies depending on 
the protein intake on the previous day. This is also expensive and not 
needed.  
Hence nowadays urinary iodine is calculated in the casual urine 
samples. These samples doesn’t need refrigeration or addition of any 
preservatives. These samples can be used even after months by 
refrigerating the sample. This is done just to prevent the development of 
bad odour. These samples can be defrozen and refrozen any number of 
times. But just before taking the aliquots for assessing the urinary iodine 
level the sample must be completely defrozen. 
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PRINCIPLE 
Iodide acts as catalyst where yellow coloured ceric ammonium 
sulphate is reduced to colourless cerous form in the presence of arsenious 
acid. This is known as sandell-kolthoff reaction. 
Before that the sample is  heated  using ammonium persulphate or 
chloric acid to get rid of the interfering substances. 
 
1. Method A: With ammonium Sulphate 
250 microlitres of urine is digested with ammonium persulphate at 
1000 C and  arsenious acid and ceric ammonium sulphate are added one 
by one. 
After 15 minutes the decrease in yellow colour is measured with 
the help of spectrophotometer.  The values are plotted on a standard curve 
and the results calculated. 
It requires heater and spectrophotometer and basic bio-chemical 
instruments and is not expensive. It needs expertise and 100 to 150 
samples can be run in a single day. 
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2. Method B : With Chloric Acid 
This method is the same as method A except that Chloric Acid is 
used in the place of ammonium persulphate for getting rid of the 
interfering substances. Chloric Acid is dangerous because the chemical 
mixture is explosive if it dries in the ventilatory system. Hence they 
recommend the use of Chloric Acid traps while doing the test. 
 
3. Modification of Method B 
This method uses ferroin, the redox indicator and stop watch 
instead of spectro photo meter for measuring the color change. The urine 
is heated with chloric acid and then the colour changes are read with stop 
watch in batches. 
This method can also be followed with ammonium persulphate 
digestion method. 
 
4. Semi Quantitative Method 
Iodide acts as a catalyst in the oxidation of 3,3’,5,5’-Tetramethyl 
benzidine by peracetic acid / hydrogen peroxide to yield yellow coloured 
products. 
Then the results are read comparing with coloured strips and given 
in 3 ranges, <100 micrograms / litre, 100 to 300 micrograms / litre and 
>300 micrograms / litre. 
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This method requires the use of prepacked columns of charcoal 
which is given by the manufacturer to remove impurities. 
 
5. Microplate Method 
By this method 400 urine samples can be read in a day. First the 
samples are heated with ammonium persulphate on microplates kept with 
in special closed cassettes and boiled to 1100C. 
Then the contents are changed to another microplate and ceric 
ammonium sulphate reduction step is done. Manufacturer supply is the 
crux in conducting these studies. 
These test are reliable, fast, inexpensive reproducible and safe. 
Method B is hazardous hence method A is used worldwide. The 
other methods are yet to be checked for their potency. 
Most of the methods for assessing iodine in urine are reliable. The 
range can be extended upward by running the tests with appropriate 
dilutions. Co efficient of variation is under 10% for all the methods. 
30 urine determinants from a group are sufficient for assessing the 
median urine excretion level in that area.  
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INTERPRETATION 
For measuring urinary iodine value of a population, median should 
be used as a measure of central tendency better than the mean. 
Percentiles rather than standard deviation must be used as a 
measure of spread. 
Frequency distribution curve will be appropriate if the salt iodine 
content is also available for the same population. 
1. Excessive iodine intake is not a problem. It causes iodine 
induced hyper thyroidism only in individuals with nodular 
goiter which could have occurred even if normal iodine was 
being utilized. 
2. When the urine iodine level is more than 300 micrograms per 
litre in iodine deficient areas, it can cause autoimmune 
thyroiditis and iodine induced hyperthyroidism in susceptible 
individuals. 
 
Thyroid size by clinical method 
This is the age old method of surveying iodine deficiency disorders 
but the increase in thyroid size takes a long time to occur. 
The thyroid gland is difficult to palpate in new borns. This method 
can be used in children of 6 to 12 years of age. 
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Technique 
Subject is made to stand in front of the examiner and the examiner 
looks for any visible thyroid gland enlargement. Then the patient is asked 
to look up and extend the neck fully. This pushes the thyroid gland 
forward and it becomes easily palpable. Palpation of the thyroid gland is 
done by gently sliding the thumb along the tracheal side between the fifth 
cervical vertebra and first thoracic vertebra. 
Another method can be used where the doctor stands behind the 
person and palpates the gland with the fingers. 
 
Ultrasound of the thyroid 
It is more reliable, non invasive and safe procedure. The results can 
be compared with the standard for that age, sex and body surface. It also 
varies for different population and countries. 
In autoimmune thyroiditis, there will be alteration in echogenecity. 
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FNAC thyroid 
1. Obtaining cell samples 
To get sufficient amount of samples for studying is not so easy. 
Studying the cytology is challenging and needs expertise. Dermal 
anaesthesia may be useful. First the thyroid mass is located with fingers. 
Then a 22- to 25 gauge needle of size 4.5 cm is poked into three different 
sites.  Syringe may or may not be used. If a cyst is palpated first it must 
be drained and then FNA of the cyst done. When the nodule is difficult to 
palpate ultrasound can be done with the help of ultrasound. 
The thyroid is a highly vascular organ and hence the aspirate may 
contain only blood. This can be stopped if the procedure is done within 5 
seconds. 
Contraindications of Thyroid FNA 
Bleeding diathesis is an absolute contraindication to FNAC as an 
hematoma collection at the aspiration site can cause tracheal compression 
and cause respiratory distress. Hence bleeding time, PT and APTT is 
mandatory before FNA thyroid. Tracheal injury and local infection are 
rare complications. By pressing the puncture site for 5 minutes, 
subcutaneous hematoma can be avoided. Hemoptysis may occur due to 
tracheal injury. 
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2. Slide preparation: 
The smears must be carefully collected and processed to yield good 
smears. Different methods are used to prepare smear depending on the 
nature of the thyroid gland. (a) One drop is kept near one end of slide and 
smeared by a cover slip. (b) A small drop of thyroid aspirate is put on a 
glass slide, crushed with a second slide that is then separated vertically 
from the first one.  A thick smear may obscure the details of the cytology 
of the gland. 
Routine staining methods 
Either air-dried and Romanowsky-stained smears or ethanol-fixed 
and Papanicolaou-stained smears can be prepared as per the need. For 
Papanicolaou staining, the smears must be fixed quickly before drying 
with a commercial spray fixative   or 95% ethanol. If fixation is delayed, 
it will result in air-dried artefactual changes and loss of cellular details. 
After Air-drying smears, one of the Romanowsky modified methods   
namely May-Grunwald-Giemsa, Wright stain, or Diff-Quik method can 
be used, as air-drying artifactual changes can be avoided. However, 
nuclear details will be well-visualized only in wet-fixed and 
Papanicolaou-stained smears.  But the use of air-dried and wet-fixed 
smears at the same time is usually recommended, as these two staining 
methods are complementary. 
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Cytodiagnosis and Its Limitations 
The cytodiagnosis of thyroid nodules by FNA is complex for the 
following reasons  
1. Cytological patterns can overlap between neoplastic and non-
neoplastic lesions. 
2. The features of different neoplasms may overlap. 
3. The same gland may contain different malignancies and also 
nonneoplatic lesions 
. 
Normal histology 
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In case of colloid goiter, there will be large uniform follicles filled 
with colloid. 
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Autoimmune thyroiditis 
 
 
 
 
 
 
 
 
 
 
Grading of thyroid gland 
Grade 0  - No lymphoid cells 
Grade 1 (Mild) - (Mild) few lymphoid cells infiltrate the follicles 
Grade 2 (Moderate)- Moderate lymphocytic infiltration with hurthle  
cell change. 
Grade 3 (Severe) - Severe florid lymphocytic infiltration with 
germinal center formation. 
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Hypothyroidism 
May be either congenital or acquired. 
 
Congenital hypothyroidism 
It affects 1 in 3000 infants, worldwide. 
Girls are more affected than boys.  
This occurs due to the absence of gland or defect in enzymes. 
 
CAUSES 
1. Primary hypothyroidism 
Defect of fetal thyroid development (dysgenesis)  
•  Aplasia 
•  Ectopia 
•  Hypoplasia 
 
Defect in thyroid hormone synthesis (dyshormonogenesis)  
•  Iodide transport defect:  there will be mutation in sodium-iodide symporter gene 
•  Thyroid organification, or coupling defect: presence of mutation in thyroid peroxidase gene 
•  Defects in H2O2 generation: mutations present in DUOXA2 maturation factor or DUOX2 gene 
•  Thyroglobulin synthesis defect: mutation of thyroglobulin gene 
•  Deiodination defect: presence of  mutation in DEHAL1 gene 
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TSH unresponsiveness  
•  Gsα mutation (e.g., type IA pseudohypoparathyroidism) 
•  Mutation of TSH receptor 
 
Defect in transport of thyroid hormone: mutation present in 
monocarboxylate transporter 8 (MCT8) gene 
 
2.Secondary hypothyroidism(pituitary) 
Pit 1 mutations 
 TSH deficiency 
 Prolactin deficiency 
 Growth hormone deficiency 
  
Iodine deficiency (endemic goiter) 
Maternal antibodies:  like thyrotropin receptor–blocking antibody 
(TRBAb, also termed thyrotropin-binding inhibitor immunoglobulin) 
Maternal Medications  
•  Iodides, amiodarone 
•  Propylthiouracil, methimazole 
•  Radioiodine 
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PROP-1 Mutations  
•  TSH deficiency 
•  Growth hormone 
deficiency   
•  Prolactin deficiency 
•  LH deficiency 
•  FSH deficiency 
•  ACTH deficiency 
 
     TSH deficiency: mutation present in TSH β subunit 
gene (Manifests as primary hypothyroidism with 
elevated TSH level). 
    Multiple pituitary deficiencies  
    (e.g., craniopharyngioma) 
TRH deficiency  
 •  Isolated or 
 
•  Multiple hypothalamic deficiencies (e.g., septo-optic 
dysplasia) 
 
TRH unresponsiveness 
Mutations present in TRH receptor 
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1. Thyroid dysgenesis - 80-85% 
  Agenesis-33% 
  Ectopic gland-66% 
2. Dyshormonogenesis - 5% 
It is an autosomal recessive disorder. Always goiter present. 
3. Transplacental thyrotropo receptor blocking antibodies-2% TSH 
cannot act on thyroid gland-hence no hormonal synthesis. 
Deiodinase defect- 
o Mono and diiodotyrosine cannot be deiodinated. 
o Hence there will be loss of iodine in urine leading on to 
hypothyroidism. 
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TRANSIENT HYROTHYROIDISM IN NEWBORN 
1. If the mother has autoimmune disorder there will be thyroid 
receptor blocking antibodies. Ultrasound will show presence of 
thyroid gland. But is not present in iodide scan. 
2. Radioiodine administration in the first year of life. 
3. Excessive iodine exposure during delivery (iodine antiseptic, 
iodine containing weeds). 
4. Preterm babies. 
 
CLINICAL FEATURES 
 Increased head size due to myxedema of brain 
 Wide open anterior and posterior fontenelle 
 Edema of eyelids, hypertelorism, depressed nasal bridge 
 Large protruded tongue leading to breathing difficulty 
 Delayed dentition 
 Brittle hair 
 Low hairline 
 Protruded abdomen, umbilical hernia 
 Delayed bone maturation 
 Sluggishness, Sleepiness 
 Prolonged cholestasis (decreased glucuronide conjugation) 
 Cardiovascular-heart murmurs, pericardial effusion 
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 General pallor(macrocytic anemia) 
 Delayed development 
 Hypotonia 
 Pseudohypertrophy 
 
Acquired hypothyroidism 
Incidence of acquired hypothyroidism is 0.3% and subclinical 
hypothyroidism is 2%. The most important cause is chronic lymphocytic 
thyroiditis with female preponderance in the ratio of 2:1. 
 
In mild iodine deficiency, the normal thyroid gland tries to adapt 
and maintains thyroid hormone production within the normal range. 
However, the prolonged thyroid hyperactivity due to such change leads to 
thyroid growth, and during proliferation of follicular cell there is a 
tendency to mutations leading to multifocal autonomous growth and 
function. 
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ETIOLOGIC CLASSIFICATION OF ACQUIRED 
HYPOTHYROIDISM 
  
Autoimmune (acquired hypothyroidism)  
• Hashimoto thyroiditis - 
• Polyglandular autoimmune syndrome, types I and II 
 -down,turner,type 1 DM 
 
Iatrogenic  
 
•  Propylthiouracil, methimazole, 
 iodides, amiodarone 
 lithium,  
thalidomide,valprate,aminogluthemide,stavudine,interferon α 
 
 •  Irradiation 
 •  Radioiodine 
 •  Thyroidectomy 
 
Systemic disease  
 • Cystinosis 
 
• Langerhans cell histiocytosis 
 
 
Hemangiomas (large) of the liver (type 3 iodothyronine deiodinase) 
Hepatitis C infection,William syndrome 
Hypothalamic-pituitary disease 
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Medications 
Amiodarone- inhibits 5’deiodinase enzyme thereby reducing the 
peripheral conversion of thyroxine to triiodothyronine. 
Methimazole and propylthiouracil are antithyroid drugs hence 
cause hypothyroidism.  Interferon α ,stavudine have autoimmunogenic 
potential-CLL like features. Hence causes thyroxine deficiency. 
Expectorants contain iodine hence by feedback mechanism they 
inhibit thyroxine production. 
Thiocyanate causes competitive inhibition of iodide transport into 
the cell and also prevents thyroglobulin from iodination. 
Propylthiouracil-blocks peroxide enzyme and prevents 
organification of tyrosine to form thyroxine. 
 
Nephropathic cystinosis-impaired thyroid function 
Langhan cell histiocytosis-infiltration of the thyroid gland by 
langhan cells causes thyroid gland destruction and hypothyroidism. 
In William syndrome and hepatitis C-there are no antibodies but 
cellular destruction occurs. 
Hemangiomas of liver have increased deiodinase activity and 
therefore increased thyroxine destruction- and hypothyroidism. 
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CLINICAL FEATURES 
 Goiter-enlargement of the thyroid gland 
May be diffuse or nodular 
May cause pressure symptoms 
 Decrease in thyroxine is compensated by increase in thyroid gland 
size 
 Weight gain, fluid retention and myxedema 
 Thin dry skin, puffy face, edematous eyelids 
 Cold intolerance, hypothermia 
 Bowel hypomotility-constipation, ileus 
 Increased sleepiness, decreased energy 
 Delirium, dementia, stupor coma 
 Muscle cramps, nerve entrapment 
 Delayed osseous maturation 
 Heart failure, ventilatory failure 
 Coagulopathy 
 Adolescents-delayed puberty,menomettrorrhagia 
 Younger children 
 Galactorrhea-increased TRH stimulates prolactin 
 Precocious thelarche, macroorchidism -TSH binds to FSH receptor 
 Headache, Vision defects 
 Hyponatremia-SIADH and impaired free water clearance 
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 Ventilatory failure-blunted hypercapnia and hypoxia 
 Heart failure-impaired ventilatory drive 
 Hypothermia, decreased response to sepsis 
 Decreased calorigenesis 
 Associated adrenal insufficiency 
 
LABARATORY FINDINGS 
 TSH levels Thyroxine levels 
Hyperthyroidism –
overt Decreased Increased 
Hyperthyroidism –
subclinical 
Decreased Normal 
Hypothyroidism –overt Increased Decreased 
Hypothyroidism –
subclinical 
Increased Normal 
 
Lymphocytic Thyroiditis (Hashimoto Thyroiditis)  
Hashimoto thyroiditis is the most common cause of thyroid disease 
in children and adolescents, and accounts for many of the “simple” goiter. 
It is also the most common cause of acquired hypothyroidism, with or 
without goiter. 
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1 to 2% of younger school-going children and 4-6% of adolescents have 
positive anti thyroid antibodies as evidence of autoimmune thyroid 
disease. 
 
Etiology 
This is an typical organ-specific autoimmune disease, characterized 
histologically by lymphocytic infiltration of the thyroid gland. Earlier, 
there may be hyperplasia only followed by infiltration of lymphocytes 
and plasma cells between the follicles, resulting in atrophy of the 
follicles. Lymphoid follicle formation with germinal centers is the 
hallmark of autoimmune thyroiditis; the degree of atrophy and fibrosis of 
the follicles may vary from mild to moderate. 
60% of infiltrating lymphoid cells are T cells and 30% are B-cells. 
The T-cell population is represented by helper (CD4+) and cytotoxic 
(CD8+) cells. 
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Pathogenesis 
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The CD8+ cytotoxic cells cause thyroid cell destruction either by 
perforin mediated cell necrosis or by granzyme-B mediated apoptosis.  T 
cell production of cytokines locally, such as tumor necrosis factor (TNF), 
IL-1, and interferon (IFN-α), may cause thyroid cells to be more 
susceptible to apoptosis mediated by death receptors, such as Fas, which 
are activated by their respective ligands on T cells. The cytokines impair 
thyroid cell function directly, and also induce the expression of many 
proinflammatory molecules by the thyroid cells themselves, such as 
cytokines, HLA class I and class II molecules, CD 40,adhesion 
molecules,  and nitric oxide . 
With the HLA haplotypes namely HLA-DR4and HLA-DR5 –there 
is increased risk of goiter and thyroiditis, HLA-DR3 is associated with 
the atrophic variant of thyroiditis. 
A variety of different thyroid antigen auto antibodies are also 
involved. Thyroid anti peroxidase antibodies (TPOAbs; also known as 
antimicrosomal antibodies) and antithyroglobulin antibodies are present 
in the sera of 90% of children with lymphocytic thyroiditis and also in 
many patients with Graves disease. 
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1. Thyroid peroxidise antibodies inhibit enzyme activity and can also 
stimulate natural killer cell cytotoxicity. 
They also fix complement resulting in destruction of thyroid 
gland.  
2. Anti thyroglobulin antibodies does not have role in the 
autoimmune destruction of the gland. 
3. Thyrotropin receptor–blocking antibodies are also present, mostly 
in patients with hypothyroidism, and it causes  hypothyroidism and 
thyroid atrophy in patients with autoimmune thyroiditis. 
4. Antibodies against pendrin, a protein present in apex on thyroid 
follicular cells is present in 80% of children with autoimmune 
thyroiditis. 
The disorder is double the time more common in girls than 
in boys. It can occur during the first 3 yr of life but becomes more 
common after 6 year of age it reaches a peak incidence during 
adolescence. The most common clinical manifestation are goiter 
and growth retardation. In most of the patients, the thyroid is 
enlarged diffusely, firm, and not tender. In about 30% of patients, 
the gland is lobular and nodular. Almost all the affected children 
are clinically euthyroid and without symptoms; some can also have 
pressure symptoms in the neck, including difficulty in swallowing 
and breathing difficulty. Some of the patients also have clinical 
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signs of hypothyroidism, but clinically euthyroid patients may have 
subclinical hypothyroidism. 
 
A few children may also have manifestations suggesting 
hyperthyroidism but there will be evidence in TSH or thyroxine. It may 
also coexist with graves disease. 
The clinical course maybe variable. Some children may persist to 
have goiter with euthyroid status. Most children who are euthyroid at 
presentation remain euthyroid, although a percentage of patients acquire 
hypothyroidism gradually within months or years. In children who 
44 
 
initially have mild or subclinical hypothyroidism i.e.elevated serum TSH, 
and normal free T4 levels, over several years 50% may revert to 
euthyroidism, and about 50% continue to have subclinical 
hypothyroidism, and a few develop overt hypothyroidism. Thyroiditis is 
the cause of most cases of nongoitrous (atrophic) hypothyroidism. 
Familial clustering of lymphocytic thyroiditis are common; the 
incidence in siblings or parents of affected children  is very high as 25%. 
Autoantibodies to thyroid peroxidase and thyroglobulin  in these families 
appear to be transmitted in an autosomal dominant fashion, with reduced 
penetrance in males.  
Autoimmune thyroiditis can occur in 10% of patients with type I 
autoimmune polyglandular syndrome, characterized by autoimmune 
polyendocrinopathy, candidiasis, and ectodermal dysplasia (APCED). 
APS-1 consists of two of the triad of hypoparathyroidism, Addison 
disease, and mucocutaneous candidiasis i.eHAM syndrome. This is also 
inherited as autosomal recessive and is caused by mutations in the 
autoimmune regulatory (AIRE) gene present on chromosome 21q22.3. 
Autoimmune thyroiditis can occur in 70% of patients with APS-2 
i.e.Schmidt syndrome. APS-2 consists of the association of Addison 
disease with type 1 diabetes mellitus (T1DM) or autoimmune thyroid 
disease. The etiology may be unknown. Autoimmune thyroid disease also 
is associated with vitiligo, pernicious anemia, or alopecia. TPO 
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Antibodies are found in approximately 20% of white people and 4% of 
black children with T1DM.  
Autoimmune thyroid disease also has an increased incidence in 
children with congenital rubella. 
Lymphocytic thyroiditis is  associated with some chromosomal 
disorders, particularly Turner syndrome and Down syndrome. In Down 
syndrome children, a study reported that 28% - antithyroid antibodies 
(mostly anti-TPOs), 7% - subclinical hypothyroidism, 7% - overt 
hypothyroidism, and 5% - hyperthyroidism. In a study of girls with 
Turner syndrome, 41% had antithyroid antibodies (again, mostly anti-
TPOs), 18%of children had goiter, and 8%of children had subclinical or 
overt hypothyroidism. 
Boys with klinefelter syndrome may also develop autoimmune 
thyroiditis.  
Hyperthyroidism 
Hyperthyroidism leads to an hypermetabolic state known as 
thyrotoxicosis characterised by elevated levels of T3 and T4. However 
this excessive release may be from preformed thyroxine as in thyroiditis 
or from extrathyroid tissue. 
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Symptoms 
Constitutional symptoms: The skin is soft, warm, and flushed; heat 
intolerance and excessive sweating can occur. Increased sympathetic 
activity and hypermetabolism can result in weight loss despite increased 
appetite. 
Gastrointestinal: Stimulation of the gut results in malabsorption, 
hypermotility, and diarrhea. 
Cardiac: Palpitations and tachycardia occurs commonly; elderly patients 
may develop congestive heart failure due to aggravation of preexisting 
heart disease. 
Neuromuscular: Patients may frequently experience nervousness, 
tremor, and irritability. Nearly 50% may be develop proximal muscle 
weakness known as thyroid myopathy. 
Ocular manifestations: A wide, staring gaze and lid lag may be  present 
because of the sympathetic overstimulation of the levator palpebrae 
superioris. 
Thyroid storm is used to define the abrupt onset of severe 
hyperthyroidism. This condition occurs mostly in individuals with 
underlying Graves disease, probably resulting from an acute rise in 
catecholamine levels, as might be encountered as during stress. 
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Diagnosis 
The diagnosis of hyperthyroidism is based on clinical features and 
laboratory data.  
The measurement of serum TSH concentration using most 
sensitive assays provides the most useful single screening test for 
hyperthyroidism, because TSH levels will be  decreased even at the 
earliest stages, when the disease has not manifested.  
In rare cases of pituitary- or hypothalamus-associated 
hyperthyroidism, i.e, Secondary, TSH levels may be either normal or 
raised. 
A low TSH value is mostly associated with increased levels of free 
thyroxine. In some of the persons, hyperthyroidism may result 
predominantly from increased circulating levels of T3 . In these cases free 
T4 levels will be decreased, and hence direct measurement of serum T3 
must be useful. 
Once the diagnosis of thyrotoxicosis is confirmed by a combination 
of TSH and free thyroid hormone assays, then measurement of 
radioactive iodine uptake by the thyroid gland can be done to determine 
the etiology.  There may be diffuse increased uptake in the whole gland 
as in Graves disease, increased uptake in a solitary nodule as in toxic 
adenoma, or decreased uptake as in thyroiditis. 
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REVIEW OF LITERATURE 
 
In a study done by rose et al, in 1999 at Baltimore hospital, 
Department of microbiology and immunology, Department of Pathology, 
there was proliferation of T cells from patients of hashimoto’s thyroiditis 
only in the presence of iodinated human thyroglobulin.  There was no 
proliferation in the presence of non iodinated thyroglobulin. 
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There may be many etiologies for chronic lymphocytic thyroiditis 
1. Genetic predisposition 
2. Environmental triggers 
Genetic predisposition: 
The occurrence of autoimmune thyroiditis in monozygotic twins 
varied from 15-50 while in dizygotic twins the occurrence was same 
as in siblings. 
This proves that susceptibility to autoimmune thyroiditis is due to 
nonheritable epigenetic factors, that is, it may be due to 
environmental triggers. 
Environmental triggers: 
Many autoimmune diseases are influenced by infections but there is 
no such microorganism influencing autoimmune thyroiditis. 
Excessive iodine is the only extensively studied environmental 
trigger influencing autoimmune thyroiditis. 
Methods by which excessive iodine may trigger autoimmune 
thyroiditis: 
1. Degeneration of free radicals 
2. Direct injury to thymocytes 
3. Inhibits the sodium iodide pump responsible for trapping 
iodide. 
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These tyrosine residues have high affinity for iodine and iodination 
in early phase occurs only in these 4 tyrosine residues.i.e. they occur only 
at these specific sites only in particular sequence. 
When iodine present in excessive amount, the other tyrosine residues 
are also iodinated. This produces a conformational change in the 
thyroglobulin molecule, thereby increasing its stability. The degree of 
iodization depends on the neighbouring groups and ionization constants 
and accessibility. When excessively iodinated, the thyroglobulin 
molecule becomes nondegradable by the cathepsins, which usually 
degrade normally iodinated thyroglobulin. 
Hence the autoimmunogenic potential of iodinated thyroglobulin is 
increased by the following mechanisms. 
1. Changes in processing of antigen 
2. Stereochemical shape alteration 
3. Production of iodine containing determinants 
4. Appearance of cryptic epitopes 
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Roitt and Coke have demonstrated that murine thyroglobulin 
reactive T cells can proliferate in the presence of human 
thyroglobulin only depending on the degree of iodisation of 
thyroglobulin. 
Their study showed that human peripheral T cells from 
chronic lymphocytic thyroiditis easily proliferated with normal 
human thyroglobulin while it was not so easy with T cells of 
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euthyroid individuals. But in the absence of traces of Iodine, none 
of the T cells were able to proliferate. Thus the degree of iodization 
of thyroglobulin determines the proliferation of T lymphocytes. 
 
Iodisation effects on immunoreactivity of human thyroglobulin 
1. Iodisation alters stereochemical configuration of thyroglobulin 
making it nondegradable. 
2. Creates a novel epitope. 
These possibilities were studied by making a panel of murine 
monoclonal antibodies to human thyroglobulin to proliferate in the 
presence of both iodinated and noniodinated thyroglobulin. There was 
significant difference suggesting loss of some epitopes and gain of some 
epitopes. 
One particular monoclonal antibody reacted with only iodinated 
but not with noniodinated thyroglobulin. The reaction of antibody with 
noniodinated thyroglobulin was restored once the thyroglobulin was 
iodinated. 
Its affinity was greater for thyroxine but there was less binding for 
triiodothyronine or reverse triiodothyronine. Hence both the position and 
number of iodine substitution on thyroxine is important in determination 
of binding capacity. 
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Autoimmune thyroiditis was studied in an animal model, NOD H2h4 
a nonobese diabetic mouse produced by crossing of NOD with B10A(4R) 
an H2k mouse. NOD H2h4 has increased incidence of spontaneous 
thyroiditis but was absent in either of the parental strains. These mice 
were given iodine by mixing it in drinking water. When the dose of 
iodine and duration of feeding was increased, the incidence of thyroiditis 
also increased in these mice. The severity of the lesion of thyroiditis was 
also proportional to thyroglobulin specific antibodies. 
The disease was transmitted to normal mice when they were given 
the spleen cells of iodine fed donors. 
Conclusion 
Presence of iodine increases the autoimmunogenic potential of 
thyroglobulin and the adoptive immunity is also transmissible. 
Chandra AK(10) et al, conducted a cross sectional study in sundarban 
delta region of West Bengal, Participants were 4656 school children.  
Objective 
Was to study the total goitre rate, thiocyanate excretion pattern of 
the school going children, urinary iodine and iodine content in edible salt 
and also in drinking water. 
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Methodology  
Children are clinically examined for goiter, urinary iodine and 
thiocyanate levels are measured, iodine content of drinking water and salt 
sample  are also measured. 
Conclusion  
Goiter prevalence was about 38.2%. Median urinary iodine level 
was 225 microg/l indicating that there is no biochemical iodine 
deficiency. They are also consuming dietary goitrogen. Environmental 
factors other than iodine deficiency may also have role for persistence of 
endemic goiter. 
 
Dilip Kumar Das(9) et al, conducted a Cross-sectional descriptive study 
in West Bengal, in 2006 which was published in the Journal of the 
American College of Nutrition, in 2008, Participants were 2400 school 
children of  age 8–10 years.  
Objective 
Was to assess the prevalence of goitre, and to measure urinary 
iodine excretion levels and to estimate salt iodine content at the 
household level. 
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Methodology 
Goitre was being assessed clinically, urinary iodine level was also 
analyzed, household salt samples were also tested to measure iodine 
content .  
Conclusion 
Total goitre rate was found to be 13.7%.Median urinary iodine 
excretion level was 13g/dL with the normal range being 10–20 g/dL. 80% 
of salt samples tested was found to have adequate iodine content. 
 
R.K Marwaha(11), Karak& N.Kochupillai had  conducted a Cross 
sectional study in 6283 healthy school girls of age 10-18years in the year 
March 1999 at All India Institute of Medical science, Delhi. 
Objective  
Was to evaluate the prevalence of goiter and also thyroid 
autoimmunity and to assess thyroid functional status in healthy school 
girls, in the different parts of the country in postiodization phase. 
Methodology 
1810 Goitrous girls 1810 were investigated for T4&TSH, 
antithyroid antibodies namely TPO and Thyroglobulin, urinary iodine and 
also cytomorphology by FNAC.  
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Results 
The prevalence of goiter was found to be 28%. The prevalence of 
juvenile autoimmune thyroiditis was found to be 7.5%.  Hypothyroidism-
6.5%, Subclinical hypothyroidism found to be -15%, Subclinical 
hyperthyroidism-5.1%. 
Conclusion 
Individuals with Juvenile Autoimmune Thyroiditis were found to 
have higher prevalence of thyroid dysfunction than without thyroiditis. 
Their study showed no correlation between urinary iodine and 
autoimmunity. 
 
Jinkou Zhao(14) et al, conducted a cross sectional study in 2371 
schoolchildren of age 6 to 15 years, and 607 adults in china and it was 
published in American Journal of Public Health, October 2000. 
Objective 
To study the relation of iodine content of the household water to 
the  thyroid size and the  urinary iodine excretion in the  area with high 
iodine concentration in the water. 
Methodology 
Iodine content of drinking water i.e. well water was measured. 
Children were assessed for thyroid size, adults were assessed for median 
urinary iodine excretion. 
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Conclusion 
Townships with a higher median level of iodine in well water had a 
1. Higher median urinary iodine concentration. 
2. Higher prevalence of goiter  
3. Higher prevalence of abnormal thyroid volume (P<.001). 
This study concluded that excess iodine in water was the cause of 
endemic goitre. 
In the case control study done by Srinivasan et al, at Institute of 
Child Health and Hospital for Children ,Chennai they proved that if UIE 
is > 300 µg /L then there is 17.94 times more chance of having 
autoimmune thyroiditis than those who have UIE < 300 µg /L. Cases 
were autoimmune thyroitis patients, controls were other goiter patients. 
90.7 % of cases (n=39) and 37.3% of controls exhibited higher than 
optimal urinary iodine excretion ( >200µg /L).  
Urinary iodine excretion was Significantly higher in children with 
autoimmune thyroiditis rather children without autoimmune thyroiditis  
A descriptive study was done by Duarte et al, in 2009 in sao poaulo 
cardiology patients. 
Objective 
Complete thyroid workup for patients who are in follow up in 
cardiology department. 
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Population-399 
Hyperthyroidism i.e overt and subclinical was present in 29 
patients (6.5%), whereas hypothyroidism i.e overt and subclinical was 
found in 32 individuals. Cysts were detected in 2.8% patients. Single 
nodules were detected in 102 (25.6%), and multinodular goiters were 
detected in 34 (8.5%). Hashimoto’s thyroiditis was present in 16.8% 
patients, most of whom were women. 
Urinary iodine excretion was more in elderly patients than in 
general population. And also more in men than women. There is higher 
prevalence of thyroid dysfunction in elderly patients. 
In a study conducted by Marwara (11)et al,in AIIMS, NEW DELHI 
goiter patients over a two year period (January 2005-December 2006) 
were studied. 
Subjects: 
695 school children of age 5-18 years were studied. 
Results: 
Overall, 16% of goitrous children had hypoechogenicity on 
ultrasound, 15.2% had cytopathological evidence of thyroiditis, 10.6% 
had positive thyroid peroxidase antibodies and 25.2% had abnormal 
thyroid function tests. Subjects with hypoechogenicity had higher 
percentage of thyroiditis on cytopathology, thyroid peroxidase antibody 
positivity and thyroid dysfunction than those with normal echogenicity. 
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Conclusion: 
 Fine Needle Aspiration Cytology is always the gold standard in the 
diagnosis of autoimmune thyroiditis. 
 Thyroid USG is always useful, but has a limited role, in excluding 
thyroid disease even in children. The sensitivity of thyroid 
ultrasonography for the diagnosis of autoimmune thyroiditis in 
children is lesser than that was reported in adults. 
A prospective study was done by Marwara et al, in Srilanka to study 
the evolution of autoimmunity during the iodization phase. 
Objective: 
Was to study the evolution of thyroid autoimmunity, in relation to 
the change in goitre prevalence, during 3 years of iodine prophylaxis in 
Sri Lanka. 
2 cohorts of girls were studied. One in 1998 and the other one in 
2001.  Prevalence of thyroid Antibody in 2001 was also lower among 
those with the Antibodies, 34.8% had Thyroglobulin Antibody alone and 
46.9% had a combination of Thyroglobulin Antibody and TPO Ab, 
compared with 82.0% Thyroglobulin Antibody alone in 1998. In 2001, 
subclinical hypothyroidism was more frequent in Ab+ (6.3%) than Ab-
negative girls (1.0%).  Only 10 of them (23.8%) remained Antibody 
positive (mostly TPO Ab and Thyroglobulin Ab) in 2001. Goiter and 
autoimmunity prevalence was significantly lower than in 1998. 
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According to an article published by Lauberg et al in the Best Res 
Endocrine Journal in 2000, even small changes in urinary iodine 
deleteriously affects the thyroid gland. 
Both low and high urinary iodine levels cause thyroid dysfunction. 
Hence they suggested that the iodisation must be curtailed according to 
the needs of the population after proper monitoring. 
In a study done by weiping tang in the department of endocrine 
metabolism in China 
 Mild iodine 
deficiency 
More than 
adequate 
Excessive 
intake 
Overt 
hypothyroidism 
0.2% 0.5% 0.3% 
Subclinical 
hypothyroidism 
0.2% 2.6% 2.9% 
Autoimmune 
thyroiditis 
0.2% 1% 1.3% 
 
Maintenance of TSH levels between 1 to 1.9 reduces the incidence 
of thyroid dysfunction. Taking Iodine more than needed causes 
hypothyroidism. 
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STUDY JUSTIFICATION 
 
The existing Universal Salt Iodization program has led to the 
reduction in IDD in endemic population groups. (1) 
 Inspite of this prevalence of goiter-13% (2)  
 Childhood hypothyroidism is 3%  
 Subclinical hypothyroidism of 10% are still seen in our country. 
Experience from southeast Asian countries also shows increase in 
detection of Juvenile autoimmune thyroiditis in post –iodization 
assessment. 
Urinary iodine-prime indicator of a person’s iodine nutritional status 
(3).  Hence this study is done to assess the iodine nutritional status in 
children with acquired hypothyroidism and healthy school children. 
 
 
 
 
 
 
 
 
62 
 
AIM & OBJECTIVE OF THE STUDY 
 
Primary Objective 
To find out the iodine nutritional status in children with acquired 
hypothyroidism of age 2-12 years attending tertiary care centre. 
 
Secondary objective 
 To assess changes in iodine nutritional status in autoimmune 
thyroiditis. 
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MATERIALS & METHODS 
 
Study Design : Descriptive study 
Study Place  : 1. Department of Pediatric Endocrinology 
Institute of Child Health and Hospital for 
Children, Egmore. 
2. Institute of Biochemistry 
    Madras Medical College. 
 
Study Period : August 2014-September 2014 
Study Population : 61 cases and 102 healthy children 
Two cohorts were selected. 
One cohort consisted of cases of acquired hypothyroidism 
attending endocrinology OPD, ICH and HC during the study period. 
 
Inclusion Criteria : 
All children with acquired hypothyroidism of age 2-12 years 
attending Endocrinology OPD during the study period i.e with TSH 
levels>5μIU/ml 
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Exclusion Criteria : 
1. Children with proven congenital hypothyroidism. 
2. Children on thyroxine and Iodine containing drugs like cough 
suppressants. 
Other cohort consisted of healthy school children of age 6-12 years 
from two different schools. 
 
Ethics involved 
Ethical committee clearance was obtained from the institutional 
review board. 
Informed consent was obtained from the parents/guardian of all the 
children involved in the study 
 
Manoeuvre 
Cases were recruited based on the inclusion and exclusion criteria 
and informed consent was obtained. History taking and clinical 
examination was done and entered in the data form. 
Goiter if present was graded according to WHO criteria 
Grade 0 - Thyroid gland invisible and not palpable  
  Grade 1 - Neck thickening not visible in normal neck 
position but palpable, thickened mass moves 
with deglutition 
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Grade 2 - Neck thickening visible during normal neck 
position corresponding to the enlarged thyroid 
gland found on palpation 
 
Thyroid function tests 
Then free thyroxine and thyroid stimulating hormone levels were 
measured using enzyme immunoassay method 
Free T4 (47-128 ng/ml) and TSH (0.5 – 5µÌU/ml)  
 
Autoimmune antibody levels 
Autoimmune antibody levels namely, anti thyroid peroxidise 
antibodies otherwise known as anti microsomal antibodies and 
thyroglobulin antibodies were measured using electrochemiluminescence 
assay. 
 anti TPO > 34 IU/ml 
 anti TG > 115 IU/ml were considered significant 
Ultrasound of thyroid gland was done in all children 
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FNAC 
Fine needle aspiration cytology of the thyroid gland was done in all 
children with goiter. 
In case of autoimmune thyroiditis, there will be 
1. Marked lymphocytic infiltration of the thyroid with formation of 
germinal center. 
2. Thyroid follicular atrophy is accompanied by oxyphil metaplasia. 
3. Absence of colloid. 
4. There may be mild to moderate fibrosis. 
In case of colloid goiter, there will be large uniform follicles filled 
with colloid. 
Children with FNAC and or autoimmune antibodies positive were 
diagnosed to have autoimmune thyroiditis. 
 
Measurement of urinary iodine 
5 ml of urine was collected in plastic screw topped containers from 
all cases and were stored in - 20 degree centigrade until it reached the 
labarotory. Then urinary iodine level was measured using Sandell-
Kolthoff reaction. 
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Principle : 
Urine is digested using ammonium persulphate. Iodine acts as a 
catalyst in the reduction of yellow coloured ceric ammonium sulphate to 
colourless cerous form and rate of colour disappearance is noted. 
 
Procedure : 
First, Urine is mixed to suspend all sediments. Then 250μl of urine 
is pipetted into 13*100 mm size test tubes. Iodine standards are also 
prepared. Then all the test tubes are heated to 100⁰c for 60 minutes and 
then cooled to room temperature. 2.5 ml of arsenious acid solution is 
added to all test tubes and made to stand for 15 minutes.300 μl of ceric 
ammonium sulphate solution is added to each test tube with quick 
mixing.  Exactly after 30 minutes of adding ceric ammonium sulphate ,its 
absorbance is read at 420 mm using calorimeter. 
 
Inference : 
A calibration curve is constructed on a graph paper by plotting 
iodide concentrations on the x axis and its optical density at 
405μg/l(OD405). 
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Epidemiological criteria to assess iodine nutrition based on median 
urine iodine concentration in school children  
 
 
Second cohort: 
A cohort of 102 healthy children from two different school in 
Chennai were selected.  5 ml of urine was collected from the children and 
urinary iodine levels were calculated. 
Children with high urinary iodine levels (>200 μg/L) were taken as 
cases. In those children, whose parents gave consent for invasive 
investigations, thyroid function tests and autoimmune antibody levels 
were done.  
Sl.No. Median urinary iodine excretion in μg/L Iodine nutritional status 
1 <20 Severe Iodine deficiency 
2 20-49 Moderate Iodine deficiency 
3 50-99 Mild Iodine deficiency 
4 100-199 Adequate iodine nutrition 
5 200-299 Above requirements 
6 >300 Excessive causing adverse side 
effects 
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In Children with visible goiter, ultrasound and FNAC thyroid was 
done. As all the children had high urinary iodine levels, the same test was 
also done in a group of 50 children in another school. 
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RESULTS 
Age Distribution 
Our study population consisted of children with acquired 
hypoyhyroidism of children between the age group of 2-12 years. 
Mean age of presentation of acquired hypothyroidism was 9.45 
years. The standard deviation was 2.54. Our lowest age of presentation 
was 3 years which was a case of autoiimune thyroiditis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chart - 1 
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Sex distribution among the cases 
 
The Female : Male ratio in our study was 2.7:1. 
 
There was a definitive female preponderance as in all other studies 
involving autoimmune thyroiditis. 
 
 
 
 
 
 
 
  
Gender Number Percentage (%) 
Girls 48 78 
Boys 13 22 
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sex distribution
male
female
 
 
 
Chart - 2 
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autoimmune thyroiditis
autoimmune 
thyroiditis
others
Autoimmune Thyroiditis 
A diagnosis of autoimmune thyroiditis was done when FNAC 
and/or antithyroid antibodies were positive. 
There were 43 cases of autoimmune thyroiditis others had some 
other cause. 
43 out of 61 had autoimmune thyroiditis with the percentage of 70. 
 
 
Chart - 3  
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Ultrasound Thyroid 
Ultrasound of the thyroid gland was done in all the cases of 
acquired hypothyroidism as it is the sensitive test to pick up thyroid 
volume as there will be inter-observer error in assessing grade 0 and 
grade 1. 
Ultrasound had reported thyromegaly in 34 cases and Thyroiditis in 
25 cases.  But only 19 out of 43 cases of autoimmune thyroiditis i.e 44 % 
had the correct USG diagnosis of thyroiditis. 
 
Chart - 4 
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Results of FNAC 
FNAC is the gold standard for diagnosing autoimmune thyroiditis. 
In one case FNAC was not done as it was not a case of goiter and the 
child had came with the complaints of excessive weight gain. 
22 out of 43 cases of autoimmune thyroiditis had lymphocytic 
infiltration in FNAC.38 cases showed excessive colloid accumulation in 
the thyroid gland. 
FNAC has diagnosed 51% of autoimmune thyroiditis cases. 
Chart - 5 
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Comparison of FNAC and ultrasound in diagnosing autoimmune 
thyroiditis 
FNAC had diagnosed 51% of autoimmune thyroiditis and USG 
thyroid had diagnosed 44%. 
 
 
Chart - 6 
 
 
 
77 
 
 
 USG FNAC 
Cases 25 21 
Proportions 0.555556 0.489 
 
Two sample test for proportions is the test done here. 
FNAC is the gold standard test. Hence here the accuracy of 
Ultrasound in diagnosing autoimmune thyroiditis is tested. 
Test statistics is 0.1781  
P value is 0.673 
That is the hypotheses that ultrasound thyroid diagnosed thyroiditis 
by chance is ruled out. USG thyroid is as efficient as FNAC in diagnosing 
thyroiditis.  
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Distribution of Anti TPO Antibodies 
The measurement of anti-TPO antibodies had diagnosed 39 out of 
43 cases which showed a percentage of 90%. 
The lowest value was 0.18 and the highest value was 2700.  
The mean value was 373.the standard deviation was 484. 
Chart - 7 
25 cases had values below 100.34 IU/L is considered as positive 
for diagnosing autoimmune thyroiditis. 37 cases out of 61 had positive 
anti TPO antibodies.39 out of 43 autoimmune thyroiditis cases had 
positive TPO antibodies. 
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Thyroglobulin Antibodies 
The mean value was 276, the standard deviation was 555.this test 
was positive in 29 out 0f 43 autoimmune thyroiditis cases. It detected 
67% cases of autoimmune thyroiditis. 
The smallest value was 0.46.it also had an eccentric value of          
> 4000. 
 
Chart - 8 
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TSH Levels 
The mean was 33 IU/ml. The standard deviation was 108. 17 cases 
had TSH value more than 25.  There was an eccentric value of 843. 
 
 
 
Chart - 9 
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WHO grading of goiter
0
1
2
Goiter Grading by Palpation 
 
2 cases had no Goiter.  While 52 cases had grade 2 goiter. 
 
 
Chart - 10 
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Urinary Iodine level Distribution 
 
Sl.No. 
Median Urinary 
Iodine excretion in 
μg/L 
Iodine Nutritional 
Status Cases 
1 <20 Severe Iodine deficiency 0 
2 20-49 Moderate Iodine 
deficiency 
0 
3 50-99 Mild Iodine deficiency 1 
4 100-199 Adequate iodine 
nutrition 
6 
5 200-299 Above requirements 13 
6 >300 Excessive causing 
adverse side effects 
41 
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Thus only one case had iodine deficiency. While 6 cases had 
normal iodine excretion,41 cases were having excessive urinary iodine 
levels. 
 
 
 
Chart – 11 
 
There was an Eccentric value of 1208 
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UIE Comparison within the cases 
Group Statistics 
 
UIE 
AIT N Mean Std. Deviation 
Std. Error 
Mean P-value 
1 43 495.65E2 288.38140 43.97775 0.009 
0 18 307.11E2 224.13225 52.82848  
 
 
Within the cases group, mean UIE was 495 for autoimmune 
thyroiditis group which was significantly higher than the other group of 
hypothyroidism. 
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* UIE Group Cross Tabulation 
   UIE Group 
Total 
   <100 100-199 
200-
299 >300 
VAR00011 
Control 
Count 0 0 1 49 50 
% within 
control .0% .0% 2.0% 98.0% 100.0% 
% within UIE 
group .0% .0% 7.1% 54.4% 45.0% 
Cases 
Count 1 6 13 41 61 
% within 
cases 1.6% 9.8% 21.3% 67.2% 100.0% 
% within UIE 
group 100.0% 100.0% 92.9% 45.6% 55.0% 
Total 
Count 1 6 14 90 111 
% within 
VAR00011 .9% 5.4% 12.6% 81.1% 100.0% 
% within UIE 
group 100.0% 100.0% 100.0% 100.0% 100.0% 
 
Fisher exact test-17.701, P-value -0.000 
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Among the cases 1.6% had iodine deficiency.67% were consuming 
excessive iodine in salt. 
Among the healthy children group, 2 had iodine deficiency with 
the lowest value of 2.5. 
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Comparing Urinary Iodine with Anti TPO antibodies in cases 
 
Chart – 12 
R value is 0.35 
R2 value is 0.127. The correlation between the change in antibody level 
and urinary iodine is very weak. 
t – 2.933 
Degree of freedom = 59 
P value = 0.04724 
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Comparing urinary iodine with thyroglobulin antibodies in 
autoimmune thyroiditis 
Chart - 13 
R value is 0.35 
R2 value is 0.049. The correlation between the change in antibody level 
and urinary iodine is very weak. 
t- 0.4458, degree of freedom=40, p value=0.65 
Correlation by pearson’s test is very weak.  There is no correlation 
between TGA and urinary iodine in autoimmune thyroiditis patients. 
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Comparing urinary iodine values of autoimmune thyroiditis patients 
and healthy school children 
 
Wilcxon-Mann whitney test was used to test the median between 
urinary iodine values of autoimmune thyroiditis and healthy school 
children. 
P value is 0.0000 
It is highly significant.   
There is no correlation between the urinary iodine values of 
autoimmune thyroiditis and healthy school children. 
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Comparing urinary iodine with anti TPO antibodies in patients with 
autoimmune thyroiditis 
 
 
Chart - 14 
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R2 value is 0.078. The correlation between the change in antibody 
level and urinary iodine is very weak. 
t- 1.8624 
Degree of freedom=41 
P value= -0.06972 
95% confidence interval (-0.02- -0.534) 
Correlation by pearson’s test is very weak.  There is no correlation 
between anti TPO antibodies and urinary iodine in autoimmune 
thyroiditis patients. 
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Comparing anti TPO antibodies and urinary iodine in healthy school 
Children 
Chart - 15 
t -1.8186 
df 38 
p -0.076 
correlation –0.2829 
There is no correlation between TPO and urinary iodine in healthy 
children. 
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Iodine Nutritional Status in healthy children  
 
Sl.No. 
Median urinary 
iodine excretion in 
μg/L 
Iodine Nutritional 
Status 
Healthy 
School 
Children 
1 <20 Severe Iodine deficiency 1 
2 20-49 Moderate Iodine 
deficiency 
0 
3 50-99 Mild Iodine deficiency 1 
4 100-199 Adequate iodine 
nutrition 
1 
5 200-299 Above requirements 1 
6 >300 Excessive causing 
adverse side effects 
98 
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Iodine Nutritional Status in healthy children  
 
 
Chart - 16 
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The mean for urine iodine excretion is 789.9.  The standard 
deviation is 269.2. 
Among the schoolchildren 1 had mild iodine deficiency and 1 had 
severe iodine deficiency. 
The urinary iodine excretion was higher than the cases. There was 
an eccentric value of 1590.9. 
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Comparing urinary iodine excretion  and TGantibodies in  healthy 
children  
 
 
Chart – 17 
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t=-0.2456 
Degree of freedom-38 
P value -0.8073 
Correlation –0.0398 
There is no correlation between urinary iodine and TG antibodies 
in healthy children.  
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DISCUSSION 
 
Autoimmune thyroiditis is the most common cause of acquired 
hypothyroidism, which has genetic predisposition and is also influenced 
by environmental triggers. This has a slight female preponderance. 
Our study also showed that 70% of the acquired hypothyroidism 
cases were due to autoimmunity. The female : male ratio was 2.7:1.mean 
age of presentation was 9.45 years. 
Chandra K et al showed the mean urine iodine value to be 225 
μg/L. Our study showed the mean urine iodine value to be 449 in cases 
and 789.9 in healthy children. 
Jinkuo Zhao et al, and Weiping et al in their studies showed that 
there is no correlation between urinary iodine and hypothyroidism. 
Srinivasan et al showed that excessive urinary iodine may trigger 
autoimmune thyroiditis. 
Chandra et al showed that environmental trigger may play a role in 
triggering autoimmunogenic potential. 
But our study showed that there is no correlation between urinary 
iodine and antibody levels both in cases as well as healthy school 
children. 
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Dilip kumar et al showed that no longer iodine deficiency is 
present. And 80% of the household were using salt which were 
adequately iodized. Our study did not measure the level of salt iodisation. 
Marwara et al showed that Ultrasound of the thyroid gland though 
useful, is not sensitive in diagnosing thyroiditis. But our study showed 
that ultrasound is as good as FNAC in diagnosing thyroiditis. 
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CONCLUSION 
 
The cause for acquired hypothyroidism and goiter is no longer 
iodine deficiency. 
The median urinary iodine excretion in the healthy school children 
was higher than that of the autoimmune thryoditis group in our study. 
In our study there was no correlation between the urinary iodine 
excretion and antithyroid antibodies. 
Thus our study contradicts the results of previous studies. 
 
Postulated hypothesis for excess urinary iodine excretion: 
Universal salt iodisation is successful in our state. The excess 
urinary iodine excretion is attributed to intake of some other goitrogens or 
iodine containing substances.    
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LIMITATIONS 
 
a. Auto immune antibody levels for all the school children could not 
be done as the parents did not give consent for invasive blood 
testing. 
b. Assessment of iodine content at the house hold level and 
production level was not done. 
c. Excessive urinary iodine in autoimmune thryoditis could not be 
attributed to excessive salt iodisation as preiodisation data is 
lacking. 
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RECOMMENDATIONS 
 
Iodine supplementation programme must be tailored only to the 
iodine deficient areas as in pre1992 era with proper monitoring of the 
iodine content at the household level and also the median urinary 
excretion level.  
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PROFORMA 
 
1. Name: 
2. Age: 
3. Gender: 
4. Endocrine department No: 
5. Parent’s name: 
6. Address: 
7. Phone number: 
8. History : 
      
• History suggestive of hypothyroidism- 
• H/o intake of goitrogens  
• H/o drug intake 
• H/o salt intake, whether iodised? 
• History suggestive of hyperthyroidism 
• H/o irradiation 
• Family history:  
 
9. Anthropometry:                                                                                                                  
-height                                                                                                                       
-weight 
-BMI percentile 
10.WHO grading of goiter: 
 
 
 
11.Thyroid function  tests: 
           T3:                 
           T4: 
           TSH: 
12.FNAC   thyroid: 
13.Thyroid auto antibodies levels: 
                      Anti-TPO: 
                      Anti-thyroglobulin: 
14.Urinary  Iodine levels: 
 
 
 
  
 
 
INFORMATION SHEET 
 IODINE NUTRITIONAL STATUS IN CHILDREN WITH 
ACQUIRED HYPOTHYROIDISM 
Investigator name :        Dr. Divya.M 
Guide                   :        Dr. S.Sundari MD ,Dch. 
(To be read to caretakers in the presence of witness) 
Hypothyroidism can cause significant growth and 
mentalretardation. Till the last decade iodine deficiency has been 
implicated as the prime cause of  hypothyroidism.. Recent studies have 
suggested that increased iodine levels may be associated with 
autoimmune thyroiditis. Hence this study is done to find out the iodine 
nutritional status in children with acquired hypothyroidism. 
How is the study being done? 
 Children with acquired hypothyroidism will be thoroughly 
evaluated by clinical history taking, clinical examination and 
investigations like thyroid function tests , FNAC, autoantibodies levels 
and urinary iodine levels .Healthy schoolchildren will be evaluated by 
history, clinical examination and urinary iodine levels. If urinary iodine 
levels are high, the children will be evaluated as cases. 2 ml of blood will 
be taken for doing thyroid function tests and autoimmune antibody levels. 
Can I refuse to join the study? 
You may refuse to participate or withdraw from the study at any 
time. In both cases your child will be treated in the usual manner in the 
hospital. 
 
 
 
Is there any benefit or harm from this study? 
Your child’s health status is known & also the data obtained can be 
used for community benefit & for the advancement of medical research. 
          There is no harm to your child from this study. 
Confidentiality: 
The data collected from the study will be used for the purpose of 
the study only. If the results of the study are to be published personal 
information of the children participating in the study will be kept 
confidential. There will not be any disclosure about your child’s 
information without your permission. 
How will your decision to not participate in the study affect your child? 
Your decisions to not to participate in this research study will not 
affect your child’s medical care or your relationship with the investigator 
or the institution. Your doctor will still take care of your child and the 
child will not lose any benefits to which he/she is entitled. 
Can you decide to stop participating in the study once you start? 
The participation in this research is purely voluntary and you have 
the right to withdraw from this study at any time during course of the 
study without giving any reasons. 
I have been fully informed about the study and the benefits to my 
child and the possible harm that can happen. 
  
 
 
This authorisation is valid only for this study. “I have understood 
and receive a copy of the consent form”. I agree for my child’s 
participation in this study. 
 
 
Signature/Thumb print of the parent/guardian: 
 
 
Signature of the investigator: 
 
 
Witness signature: 
 
Date: 
 
Principal investigator: 
 
Address: 
 
Phone:  
 
 
 
CONSENT FORM 
STUDY PLACE : INSTITUTE OF CHILD HEALTH AND 
HOSPITAL FOR CHILDREN, ENDOCRINOLOGY OPD 
TITLE OF THE STUDY: IODINE NUTRITIONAL STATUS IN 
CHILDREN WITH ACQUIRED HYPOTHYROIDISM 
Name of the Investigator :  Dr.M.DIVYA      
Name of the Participant :  Age:   Sex: 
Hospital number  :  Endocrine  no: 
    
1. I have read and understood this consent form and the information 
provided to me regarding the participation in the study.  
2. I have had the consent document explained to me.  
3. I have been explained about the nature of the study.  
4. I have been explained about my rights and responsibilities by the 
investigator.  
5. I have informed the investigator of all the treatments I am taking or 
have taken in the past including any native (alternative) treatment.  
6. I agree to cooperate with the investigator and I will inform him/her 
immediately if I suffer unusual symptoms. * 
7. I have not participated in any research study in the past. 
8. I am aware of the fact that I can opt out of the study at any time 
without having to give any reason and this will not affect my future 
treatment in this hospital. * 
9. I am also aware that the investigator may terminate my participation in 
the study at any time, for any reason, without my consent. * 
10. I hereby give permission to the investigators to release the 
information obtained from me as result of participation in this study to the 
sponsors, regulatory authorities, Govt. agencies, and IEC. I understand 
that they are publicly presented.  
 
 
11. I have understood that  my  identity will be kept confidential if my 
data are publicly presented  
12. I have had my questions answered to my satisfaction.  
13. I have decided to be in the research study.  
I am aware that if I have any question during this study, I should contact 
the investigator. By signing this consent form I attest that the information 
given in this document has been clearly explained to me and understood 
by me, I will be given a copy of this consent document. For adult 
participants:  
Name and signature /parents/guardian  
Name______________ Signature___________ Date___________  
Name and Signature of impartial witness:  
Name____________ Signature_________________ Date_____________ 
Name and Signature of the investigator or his representative obtaining 
consent:  
Name______________ Signature_____________ Date____________ 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART 
School Children 
1 V.MANIKANDAN 3.10.06 7 M 26 1.24 16.9 878.1         
2 J.PRABHAKARAN 31.12.06 7 M 19 1.14 14.6 779.1 1.29 3.15 1.08 0.53 
3 S.AKASH 23.10.06 7 M 18 1.17 13.2 600.4 1.27 3.97 1.98 0.22 
4 T.MATHEW JOHN 7.01.07 7 M 18 1.18 12.9 311.6 1.42 3.18 1.42 0.16 
5 D.YUGESH 7.04.07 7 M 20 1.21 13.7 202.1 1.78 1.61 2.53 0.52 
6 A.ALVINRAJ 23.04.06 8 M 21 1.21 14.3 878.1         
7 D.DEVAKUMAR 21.11.06 7 M 21 1.26 13.2 444.3         
8 J.GNANASEKAR 19.06.06 8 M 20 1.23   519.4 1.47 1.88 0.94 0.49 
9 A.HARIDOSS 1.06.06 8 M 16 1.15 13.2 1208 1.46 1.89 2.17 0.57 
10 V.SANJAY 2.10.06 7 M 22 1.2 15.3 519.4 1.42 1.88 1.77 1.15 
11 NAINAR MOHAMMED 27.04.07 7 M 20 1.18 14.4 600.4 1.18 7.87 79.35 0.78 
12 AJITH KUMAR 26.10.06 7 M 25 1.24 16.3 444.3 1.62 2.91 4.17 0.41 
13 N.ANGEL JAYANTH 10.09.06 8 F 26 1.26 16.4 444.3 1.36 2.5 2.43 0.56 
14 EMIMA 26.12.06 7 F 20 1.23 13.2 444.3 1.18 2.63 1.68 1.12 
15 A.JAYAPRAKASH 14.03.07 7 M 25 1.33 14.1 600.4 1.33 2.25 1.49 1.46 
16 C.VIJAY 31.05.07 7 M 18 1.16 13.4 444.3 1.28 1.43 1.41 0.04 
17 B.KARTHIKEYAN 18.05.07 7 M 22 1.24 14.3 519.4         
18 V.RADHAKRISHNAN 27.08.07 7 M 23 1.22 15.5 519.4 1.29 2.66 0.71 1.24 
19 M.MUTHU 6.09.06 8 M 20 1.23 13.2 519.4 1.39 2.86 1.71 2.54 
20 D.SAMUEL 10.03.07 7 M 25 1.33 14.1 311.6 1.64 1.34 2.51 0.47 
21 D.IMMANUEL 04.06.07 7 M 22 1.2 15.3 779.7 1.24 2.47 1.35 1.17 
22 S.KISHORE KUMAR 6.12.06 7 M 23 1.19 16.2 687.1 1.29 1.69 1.99 1.08 
23 D.SARATHY 24.08.06 8 M 18 1.2 12.5 600.4         
24 harish 17.02.07 7 M 23 1.32 13.2 1208.3 1.47 1.99 1.89 0.26 
25 S.SANJAY 20.02.07 7 M 21 1.17 15.3 982.3 1.33 4.12 1.72 0.13 
26 P.SANTHOSH 08.03.07 7 M 21 1.22 14.1 444.3         
27 M.ABIRAMI 24.02.07 7 F 20 1.14 15.4 878.1 1.29 2.3 2.02 0.85 
28 P.RUBINI 06.06.07 7 F 20 1.14 15.4 600.4         
29 S.SWAPNA 06.07.05 9 F 26 1.28 15.8 982.3 1.21 1.76 4.38 0.25 
30 R.MALINI 24.08.06 8 F 22 1.27 13.6 878.1 1.55 1.87 1.75 1.13 
31 C.S.ASHMITHA 06.04.07 7 F 24 1.21 16.4 779.7 1.54 3.05 4.11 0.3 
32 S.SUBATHRA 13.02.07 7 F 20 1.23 13.2 519.4 1.19 1.47 6.87 12 
33 S.KEERTHANA 16.06.07 7 F 20 1.16 14.9 687.1 1.74 1.79 1.37 0.21 
34 S.SUJI 10.04.07 7 F 20 1.24 13 687.1         
35 A.MONISHA 20.06.07 7 F 18 1.21 12.3 878.1 1.3 2.06 3.44 0.3 
36 P.NALINI 20.06.05 9 F 20 1.14 15.4 982.3 1.4 4.99 2.19 0.29 
37 A.PRAVEENA 20.06.06 8 F 25 1.24 16.3 600.4         
38 L.SAMUEL 11.07.06 8 M 15 1.19 10.6 982.3 1.44 3.92 1.21 0.15 
39 T.ABISHEK 29.03.06 8 M 18 1.2 12.5 600.4         
40 R.VIGNESH 31.03.06 8 M 13 1.29 7.8 519.4 1.14 2.06 2.55 0.89 
41 Y.VASANTH 7.02.06 8 M 25 1.39 12.9 519.4 1.41 3.07 1.41 0.49 
42 A.YASWANTH 14.10.05 8 M 22 1.29 13.2 519.4 1.4 3.6 4.24 0.63 
43 M.MANO 13.04.06 8 M 17 1.27 10.5 779.7 1.56 3.03 3.61 1.68 
44 S.BARATH 19.06.06 8 M 27 1.33 15.3 687.1 1.5 0.973 2.12 2.59 
45 A.DHANALAKSHMI 16.11.04 7 F 23 1.28 14 878.1 1.36 1.55 1.63 0.34 
46 S.DARSINI 17.03.05 9 F 25 1.32 14.3 878.1 1.24 0.914 15.51 0.73 
47 P.SUSEELA 1.10.05 8 F 16 1.23 10.6 311.6 1.38 2.36 5.22 16.01 
48 D.VIJAYALAKSHMI 13.04.05 9 F 27 1.36 14.6 519.4 1.48 1.62 1.8 0.27 
49 CHRISTOPHER 22.09.06 8 M 48 1.4 24.5 878.1 1.22 3.59 2.47 0.6 
50 K.SUGUNA 11.11.05 8 F 19 1.23 12.6 982.3 1.31 2.1 2.29 0.14 
51 K.UDHAYAKUMAR   8 M       156.1         
52 S.SAKTHIVEL   8 M       982.3         
53 K.SANJAYRAMAN   8 M       989         
54 M.SARAVANAN   8 M       878.1         
55 M.DHANASEKAR   8 M       1208         
56 M.DINESHKUMAR   8 M       989         
57 M.LOKESH   8 M       982.3         
58 R.VIMALADHITHAN   8 M       989         
59 J.K.VENKATESH   8 M       878.1         
60 AFRA THASLIM   9 F       878.1         
61 P.BHARATHY   8 F       878.1         
62 A.LOSHINI   8 F       878.1         
63 N.BARATHRAJ   8 M       982.3         
64 M.ASHOK   10 M       982.3         
65 R.UDHAYAKUMAR   9 M       989         
66 M.MANIKANDAN   10 M       878.1         
67 D.PRAVEEN FRANCIS   9 M       878.1         
68 J.SHETRAJ   8 M       1208         
69 S.YUVARAJ   9 M       53.1         
70 ASARUDEEN   8 M       1012         
71 A.GAYATHRI   9 F       1012         
72 V.SHANTHALAKSHMI   8 F       2.5         
73 D.DIVYA   10 F       989         
74 M.DEEPASHREE   9 F       878.1         
 
 
 
 
 
 
 
  
  
75 K.BANUPRIYA   8 F       779.7         
76 B.MALINI   9 F       989         
77 A.VELANKANNI   9 F       878.1         
78 P.RAKSHANA   9 F       982.3         
79 S.FATHIMA   9 F       989         
80 A.ANBUSELVI   7 F       779.7         
81 B.SWETHA   7 F       878.1         
82 N.RAJALAKSHMI   9 F       1208         
83 M.MUTHARASU   8 F       982.3         
84 A.IMANRAJ   7 M       982.3         
85 M.KEERTHANA   10 F       687.1         
86 S.DIVYA   10 F       779.7         
87 T.MONISHA   10 F       982.3         
88 K.LAVANYA   11 F       982.3         
89 S.MEENATCHI   11 F       779.7         
90 B.SWATHI   11 F       687.1         
91 R.NAVEENKUMAR   11 M       779.7         
92 S.GOPINATH   11 M       982.3         
93 R.SURYAPRAKASH   10 M       878.1         
95 D.DHAYABABU   11 M       1012         
96 S.HARISH   10 M       1012         
97 S.HARISHKUMAR   10 M       982.3         
98 M.JEEVA   10 M       998         
99 A.MANIKANDAN   10 M       1012         
100 R.DINESH   10 M       1012         
101 A.RAKESH   11 M       1012         
102 K.LOKESH   10 M       982.3         
94 M.SANJAY   11 M       1590.9         
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1 Madani 6 F 88/12 22 1.12 
    
17.5
4  0 >25 24 nd N 74 
>100
0 180 1 OVERT 
2 aswini 11 F 61/13 24 1.25 
    
15.4
0  1 
18.0
5 
11.
1 colloid 
thyromeg
aly 579 
>400
0 444.3 1 OVERT 
3 revathy 11 F 63/13 27 1.26 
    
17.0
0  1 11.9 
15
0 colloid 
thyromeg
aly 25 104 253.9 0 
SUBCLINIC
AL 
4 divya 10 F 37/13 25 1.22 
    
16.8
0  2 7.2 84 colloid thyroiditis 22 34 202.1 0 
SUBCLINIC
AL 
5 shalini 12 F 
1172/1
3 16.8 1.16 
    
15.9
0  2 >25 68 colloid 
thyromeg
aly 215 567 375 1 
SUBCLINIC
AL 
6 dinesh 3 M 597/13 10 0.91 
     
12.1
0  2 6.27 11 colloid 
thyromeg
aly 28 45 311.6 0 OVERT 
7 sameena 9 F 612/13 26 1.27 
    
16.0
0  2 
19.9
4 
5.2
6 
thyroidit
is thyroiditis >100 
>100
0 202.1 1 
SUBCLINIC
AL 
8 
udayakum
ar 3 M 125/12 11 0.9 
    
13.6
0  2 12.4 67 colloid 
thyromeg
aly 153.6 16.8 600.4 1 
SUBCLINIC
AL 
9 mohana 8 F 439/13 24 1.16 17.8 1 >25 58 
thyroidit
is 
thyromeg
aly 1000 
185.7
3 878.1 1 
SUBCLINIC
AL 
10 Gowri 10 F 547/13 24 1.25 
    
15.4
0  2 28.1 
5.0
3 
thyroidit
is 
thyromeg
aly 4.98 64 253.9 1 
SUBCLINIC
AL 
11 preetha 11 F 557/13 26 1.28 
    
15.8
0  1 12 6.2 colloid 
thyromeg
aly 23.6 22.26 375 0 
SUBCLINIC
AL 
12 lekhasree 11 F 232/13 25 1.27 
    
15.5
0  2 16 67 colloid thyroiditis 0.72 1.21 375 0 
SUBCLINIC
AL 
13 divya 11 F 628/13 27 1.26 
    
17.0
0  2 149 
0.5
1 colloid thyroiditis 124 325 375 1 
SUBCLINIC
AL 
14 lokesh 9 M 636/13 27 1.26 
    
17.0
0  2 
15.3
3 34 colloid 
thyromeg
aly 456 700 444.3 1 OVERT 
15 jenifer 10 F 648/13 27 1.26 
    
17.0
0  2 7.2 56 colloid 
thyromeg
aly 16 58 311.6 0 
SUBCLINIC
AL 
16 anbarassi 5 F 650/13 18 1.08 
    
15.4
0  2 >25 46 
thyroidit
is thyroiditis 
>100
0 34.19 375 1 OVERT 
17 rekha 8 F 652/13 22 1.24 14.3 2 8.3 86 
thyroidit
is thyroiditis 
548.2
7 
711.9
2 311.6 1 
SUBCLINIC
AL 
18 abirami 10 F 123/13 26 1.27 
    
16.0
0  2 6.2 76 colloid 
thyomegal
y 163 320 444.3 1 
SUBCLINIC
AL 
19 harini 10 F 726/13 27 1.26 
    
17.0
0  2 9.4 
10.
3 colloid 
thyromeg
aly 28 15 116 0 OVERT 
20 ajay 11 M 423/13 21 1.32 
    
12.4
2  2 6.8 65 
thyroidit
is 
thyomegal
y 23 329 311.6 1 
SUBCLINIC
AL 
21 sabana 10 F 759/13 24 1.25 
    
15.4
0  2 8.1 7.6 
thyroidit
is thyroiditis 
>100
0 52.34 375 1 
SUBCLINIC
AL 
22 hariharan 10 M 241/13 27 1.26 
    
17.0
0  2 7 35 colloid N 31.5 <15 253.9 1 OVERT 
23 
naveen 
kumar 8 M 
2451/1
3 23 1.22 15.5 1 8.9 92 colloid 
thyromeg
aly 303.2 162 202.1 1 
SUBCLINIC
AL 
24 gajendran 7 M 696/12 24 1.18 
    
17.2
3  2 7.17 0.7 colloid thyroiditis 1.02 0.66 53 0 
SUBCLINIC
AL 
25 ammu 11 F 797/13 24 1.16 
    
17.8
0  2 12.3 
7.7
8 
thyroidit
is thyroiditis 98 105 156.1 1 OVERT 
26 harini 9 F 829/13 24 1.25 
    
15.4
0  2 12.6 58 
thyroidit
is 
thyromeg
aly 52 48 1590.9 1 
SUBCLINIC
AL 
27 abirami 11 F 13/14 27 1.25 
    
17.3
0  2 6.8 94 colloid thyroiditis <3 1.53 116 0 
SUBCLINIC
AL 
28 aswini 11 F 579/13 32 1.28 
    
19.5
0  2 >25 84 
thyroidit
is thyroiditis 170 402 375.4 1 
SUBCLINIC
AL 
29 nishanthi 12 F 56/14 24 1.16 
    
17.8
0  2 6.4 
10
2 colloid thyroiditis 0.24 1.58 311.6 0 
SUBCLINIC
AL 
30 jeyamani 11 F 821/13 23 1.21 
    
15.7
0  2 8 
5.3
3 colloid 
thyromeg
aly 
329.6
4 192.3 444.3 1 OVERT 
31 yamini 10 F 42/14 24 1.25 
    
15.4
0  2 7 42 colloid 
thyomegal
y 24 42 116 0 OVERT 
32 sneha 12 F 117/14 23 1.21 
    
15.7
0  2 23 
1.6
2 colloid 
thyromeg
aly 21 55 779.3 0 
SUBCLINIC
AL 
  
 
 
 
33 riswana 10 F 
148/1
4 25 1.27 
    
15.5
0  2 6.5 
11.
5 colloid 
thyromegal
y 24 46 687.1 0 OVERT 
34 indra 11 F 
154/1
4 28 1.31 
    
16.3
0  2 
27.8
7 5.5 
thyroiditi
s thyroiditis 540 242 311.6 1 OVERT 
35 nivedha 9 F 
155/1
4 25 1.27 
    
15.5
0  2 33.7 
44.
4 
thyroiditi
s thyroiditis 343 156 600.4 1 OVERT 
36 
lokeshwara
n 7 M 
186/1
4 20 1.23 13.2 2 10.2 54 colloid thyroiditis >1000 322 600.4 1 
SUBCLINIC
AL 
37 karima 12 F 
487/1
4 28 1.31 
    
16.3
0  2 
84.6
4 
17.
7 colloid thyroiditis 4.55 
136.5
8 253.9 1 OVERT 
38 thulasi 11 F 
206/1
4 16.8 1.16 
    
15.9
0  2 42 22 colloid 
thyromegal
y 592 423 375 1 OVERT 
39 gayathri 11 F 
215/1
4 24 1.16 
    
17.8
0  2 
23.2
3 
0.5
3 
thyroiditi
s thyroiditis 
577.9
7 
156.5
8 202.1 1 
SUBCLINIC
AL 
40 vinodhini 8 F 
213/1
4 20 1.3 
     
11.8
0  1 7.3 
6.9
5 colloid thyroiditis >1000 8.24 253.9 1 OVERT 
41 mohanasri 5 F 
259/1
4 20 1.09 
    
16.8
0  2 6.5 64 colloid 
thyromegal
y 
750.4
5 72.2 687.1 1 
SUBCLINIC
AL 
42 monisha 11 F 
277/1
3 43 1.55 
    
17.9
0  2 8.3 56 
thyroiditi
s thyroiditis 289 4.15 600.4 1 
SUBCLINIC
AL 
43 uthra 10 F 
288/1
3 29 1.42 
    
14.4
0  2 15 3 
thyroiditi
s thyroiditis 1300   1208 1 OVERT 
44 akila 11 F 
305/1
4 24 1.22 
     
16.1
2  2 14 
96.
5 colloid thyroiditis >1000 >1000 375 1 
SUBCLINIC
AL 
45 riya 9 F 
389/1
4 30 1.32 
    
17.2
0  2 7 53 colloid thyroiditis 32 39 116 0 
SUBCLINIC
AL 
46 nagamani 11 F 
401/1
4 36 1.45 
    
17.2
0  2 7.26 65 colloid 
thyromegal
y 6.6 4.75 779.7 0 
SUBCLINIC
AL 
47 gokulraj 11 M 
498/1
4 21 1.32 
    
12.0
5  2 9.7 45 colloid 
thyromegal
y 592 340 444.3 1 
SUBCLINIC
AL 
48 ajithkumar 11 M 
504/1
3 23 1.21 
    
15.7
0  2 843 
0.6
5 
thyroiditi
s thyroiditis 
747.1
6 42.87 519.4 1 
SUBCLINIC
AL 
49 vani 11 F 
530/1
4 28 1.31 
    
16.3
0  2 7.73 
0.8
4 colloid thyroiditis >1000 27.8 253.9 1 
SUBCLINIC
AL 
50 bavani 11 F 
547/1
4 35 1.31 
   
20.4
0  0 
13.7
1 5 colloid 
thyromegal
y 18 42 202.1 0 OVERT 
51 yuvasree 11 F 
113/1
3 28 1.31 
    
16.3
0  2 6.5 96 colloid 
thyromegal
y 
709.8
5 
133.4
1 444.3 1 
SUBCLINIC
AL 
52 jeyasakthi 12 F 25/13 45 1.5 
   
20.0
0  2 >25 1 colloid 
thyromegal
y >1000 762 687.1 1 
SUBCLINIC
AL 
53 mithra 8 F 
334/1
3 23 1.28 14 2 >25 49 colloid 
thyomegal
y 215 158 375 1 
SUBCLINIC
AL 
54 chandra 9 F 
806/1
3 25 1.27 
    
15.5
0  2 12 56 
thyroiditi
s 
thyromegal
y 143 260 687.1 1 
SUBCLINIC
AL 
55 nisha 4 F 
429/1
3 13 0.96 14.1 2 19 5.4 
thyroiditi
s 
thyromegal
y 201 253 600.4 1 OVERT 
56 kaviyarasu 8 M 
412/1
3 26 1.22 17.4 2 
13.1
7 
0.9
1 colloid 
thyromegal
y 0.18 0.93 211 0 
SUBCLINIC
AL 
57 issac 10 M 
704/1
3 25 1.28 
    
15.2
6  2 
116.
5 4.3 
thyroiditi
s thyroiditis 2700 450 878.1 1 OVERT 
58 
priyadarsin
i 7 F 
286/1
1 25 1.33 14.1 2 >25 67 
thyroiditi
s 
thyromegal
y 305 495 982.3 1 
SUBCLINIC
AL 
59 lokesh 6 M 73/12 21 1.11 
    
17.0
0  1 7.3 49 
thyroiditi
s 
thyomegal
y 45.89 
102.1
5 600.4 1 
SUBCLINIC
AL 
60 amul 12 F 
504/1
2 25 1.24 
    
16.2
6  2 >25 94 colloid 
thyromegal
y 2.1 4.3 211 0 
SUBCLINIC
AL 
61 kavya 9 F 
677/1
2 24 1.28 
    
14.6
0  2 18 16 
thyroiditi
s 
thyromegal
y >1000 287 779.7 1 OVERT 
 
